Meningococcal factor H binding protein as immune evasion factor and vaccine antigen

被引:15
|
作者
Principato, Silvia [1 ,2 ]
Pizza, Mariagrazia [1 ]
Rappuoli, Rino [1 ]
机构
[1] GSK, Siena, Italy
[2] Univ Siena, Siena, Italy
关键词
4CMenB; complement binding; factor H binding protein; fHbp; GNA1870; human factor H; immune evasion mechanisms; rLP2086; vaccine antigen; COMPLEMENT FACTOR-H; NEISSERIA-MENINGITIDIS; MONOCLONAL-ANTIBODIES; BACTERICIDAL ACTIVITY; ALTERNATIVE PATHWAY; VIRULENCE FACTOR; CANDIDATE; ACID; IMMUNOGENICITY; SEQUENCE;
D O I
10.1002/1873-3468.13793
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Factor H binding protein (fHbp) is a key virulence factor of Neisseria meningitidis and a main component of the two licensed vaccines against serogroup B meningococcus (Bexsero and Trumenba). fHbp is a surface-exposed lipoprotein that enables the bacterium to survive in human blood by binding the human complement regulator factor H (fH). When used as vaccine, the protein induces antibodies with potent bactericidal activity. While the fHbp gene is present in the majority of N. meningitidis serogroup B isolates, the expression level varies up to 15 times between different strains and more than 700 different sequence variants have been described. Antigenically, the protein has been divided into three variants or two subfamilies. The 3D structure of fHbp alone, in combination with fH or in complex with bactericidal antibodies, has been key to understanding the molecular details of the protein. In this article, we will review the biochemical and immunological properties of fHbp, and its key role in meningococcal pathogenesis, complement regulation, and immune evasion.
引用
收藏
页码:2657 / 2669
页数:13
相关论文
共 50 条
  • [21] Complement-dependent synergistic bactericidal activity of antibodies against factor H-binding protein, a sparsely distributed meningococcal vaccine antigen
    Welsch, Jo Anne
    Ram, Sanjay
    Koeberling, Oliver
    Granoff, Dan M.
    JOURNAL OF INFECTIOUS DISEASES, 2008, 197 (07): : 1053 - 1061
  • [22] Immune evasion of Candida albicans: Identification and characterization of factor H binding proteins
    Luo, Shanshan
    Poltermann, Sophia
    Zipfel, Peter F.
    MOLECULAR IMMUNOLOGY, 2008, 45 (16) : 4170 - 4171
  • [23] Hijacking Factor H for Complement Immune Evasion
    Moore, Sara R.
    Menon, Smrithi S.
    Cortes, Claudio
    Ferreira, Viviana P.
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [24] Design of Meningococcal Factor H Binding Protein Mutant Vaccines That Do Not Bind Human Complement Factor H
    Pajon, Rolando
    Beernink, Peter T.
    Granoff, Dan M.
    INFECTION AND IMMUNITY, 2012, 80 (08) : 2667 - 2677
  • [25] Distinct Binding and Immunogenic Properties of the Gonococcal Homologue of Meningococcal Factor H Binding Protein
    Jongerius, Ilse
    Lavender, Hayley
    Tan, Lionel
    Ruivo, Nicola
    Exley, Rachel M.
    Caesar, Joseph J. E.
    Lea, Susan M.
    Johnson, Steven
    Tang, Christoph M.
    PLOS PATHOGENS, 2013, 9 (08)
  • [26] Cooperative serum bactericidal activity between human antibodies to meningococcal factor H binding protein and Neisserial heparin binding antigen
    Vu, David M.
    Wong, Tracy T.
    Granoff, Dan M.
    VACCINE, 2011, 29 (10) : 1968 - 1973
  • [27] Immune evasion of pathogenic moulds by acquisition of complement factor H and C4b binding protein
    Vogl, G.
    Lesiak, I.
    Speth, C.
    Lass-Floerl, C.
    Zipfel, P. F.
    Blom, A. M.
    Dierich, M. P.
    Wuerzner, R.
    MYCOSES, 2007, 50 (05) : 340 - 340
  • [28] Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease
    Jiang, Han-Qing
    Hoiseth, Susan K.
    Harris, Shannon L.
    McNeil, Lisa K.
    Zhu, Duzhang
    Tan, Cuiwen
    Scott, Adrienne A.
    Alexander, Kristin
    Mason, Kathryn
    Miller, Lynn
    DaSilva, Ida
    Mack, Michelle
    Zhao, Xiao-Juan
    Pride, Michael W.
    Andrew, Lubomira
    Murphy, Ellen
    Hagen, Michael
    French, Roger
    Arora, Ashoni
    Jones, Thomas R.
    Jansen, Kathrin U.
    Zlotnick, Gary W.
    Anderson, Annaliesa S.
    VACCINE, 2010, 28 (37) : 6086 - 6093
  • [29] Meningococcal factor H-binding protein vaccines with decreased binding to human complement factor H have enhanced immunogenicity in human factor H transgenic mice
    Rossi, Raffaella
    Granoff, Dan M.
    Beernink, Peter T.
    VACCINE, 2013, 31 (46) : 5451 - 5457
  • [30] Importance of Inhibition of Binding of Complement Factor H for Serum Bactericidal Antibody Responses to Meningococcal Factor H-binding Protein Vaccines
    Konar, Monica
    Granoff, Dan M.
    Beernink, Peter T.
    JOURNAL OF INFECTIOUS DISEASES, 2013, 208 (04): : 627 - 636